Evidence map›Paper›PMID 24816905›Full record

ArticlePloS one2014

Single nucleotide variants in the protein C pathway and mortality in dialysis patients.

Gürbey Ocak, Christiane Drechsler, Carla Y Vossen, Hans L Vos, Frits R Rosendaal, Pieter H Reitsma, Michael M Hoffmann, Winfried März, Willem H Ouwehand, Raymond T Krediet and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of pharmacogenomics in dialysis and transplantation.Current opinion in nephrology and hypertension · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Gürbey OcakDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Christiane DrechslerDepartment of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany; Comprehensive Heart Failure Center, University of Wuerzburg, Wuerzburg, Germany; Institute of Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
Carla Y VossenDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Hans L VosDepartment of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Frits R RosendaalDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Pieter H ReitsmaDepartment of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Michael M HoffmannInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center, Freiburg, Germany.
Winfried MärzDepartment of Public Health, Social and Preventive Medicine, University of Heidelberg, Mannheim, Germany.
Willem H OuwehandDepartment of Hematology, University of Cambridge and National Health Service Blood and Transplant, Cambridge, United Kingdom; Department of Human Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Raymond T KredietDepartment of Nephrology, Academic Medical Center, Amsterdam, The Netherlands.
Elisabeth W BoeschotenHans Mak Institute, Naarden, The Netherlands.
Friedo W DekkerDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Christoph WannerDepartment of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany; Comprehensive Heart Failure Center, University of Wuerzburg, Wuerzburg, Germany.
Marion VerduijnDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Leiden University Medical Center · NLAcademic Medical Center · NLComprehensive Cancer Center Mainfranken · DEHeidelberg University · DENefrovisie · NLUniversity Medical Center Freiburg · DEUniversity of Würzburg · DEWellcome Sanger Institute · GB

Funding

British Heart Foundation RG/09/012/28096Department of Health RP-PG-0310-1002
6 · The paper itself

Abstract

backgroundThe protein C pathway plays an important role in the maintenance of endothelial barrier function and in the inflammatory and coagulant processes that are characteristic of patients on dialysis. We investigated whether common single nucleotide variants (SNV) in genes encoding protein C pathway components were associated with all-cause 5 years mortality risk in dialysis patients.

methodsSingle nucleotides variants in the factor V gene (F5 rs6025; factor V Leiden), the thrombomodulin gene (THBD rs1042580), the protein C gene (PROC rs1799808 and 1799809) and the endothelial protein C receptor gene (PROCR rs867186, rs2069951, and rs2069952) were genotyped in 1070 dialysis patients from the NEtherlands COoperative Study on the Adequacy of Dialysis (NECOSAD) cohort) and in 1243 dialysis patients from the German 4D cohort.

resultsFactor V Leiden was associated with a 1.5-fold (95% CI 1.1-1.9) increased 5-year all-cause mortality risk and carriers of the AG/GG genotypes of the PROC rs1799809 had a 1.2-fold (95% CI 1.0-1.4) increased 5-year all-cause mortality risk. The other SNVs in THBD, PROC, and PROCR were not associated with 5-years mortality.

conclusionOur study suggests that factor V Leiden and PROC rs1799809 contributes to an increased mortality risk in dialysis patients.

Indexed as

Antigens, CDEndothelial Protein C ReceptorFactor VGermanyHumansNetherlandsPolymorphism, Single NucleotideProtein CReceptors, Cell SurfaceRenal DialysisSignal TransductionThrombomodulinAntigens, CDEndothelial Protein C ReceptorFactor Vfactor V LeidenPROCR protein, humanProtein CReceptors, Cell SurfaceThrombomodulin

Identifiers

PMID24816905
PMCPMC4016291
OpenAlexW2063204383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.